Radiotherapy and genetic predisposition to breast cancer

Clinical Oncology

Volumn 18, Issue 3, 2006, Pages 257-267

  Turnbull, C ^a   Mirugaesu, N ^b   Eeles, Rosalind ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

BRCA; Breast cancer; Cancer risk after radiotherapy; Genetic predisposition; Radiotherapy; Syndromes predisposing to radiation toxicity; TP53

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; ESTROGEN RECEPTOR; MRE11 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; PROTEIN P53; RAD50 PROTEIN; RAD51 PROTEIN; RAS PROTEIN; RECQ HELICASE; RETINOBLASTOMA PROTEIN;

ATAXIA TELANGIECTASIA; BASAL CELL NEVUS SYNDROME; BLOOM SYNDROME; BREAST CANCER; CANCER GENETICS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHROMOSOME BREAKAGE; CLINICAL TRIAL; COMMON VARIABLE IMMUNODEFICIENCY; COWDEN SYNDROME; DOWN SYNDROME; FANCONI RENOTUBULAR SYNDROME; FOLLOW UP; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HETEROZYGOTE; HUMAN; IONIZING RADIATION; KLINEFELTER SYNDROME; MISSENSE MUTATION; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; PENETRANCE; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; RADIATION SAFETY; RADIOSENSITIVITY; RETINOBLASTOMA; REVIEW; ROTHMUND THOMSON SYNDROME; SKIN EXFOLIATION; TREATMENT CONTRAINDICATION; WERNER SYNDROME;

EID: 33144471300     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.11.013     Document Type: Article

References (104)

1. P.P. Broca Traites des tumeurs 1866 Asselin Paris
2. J.M. Hall M.K. Lee B. Newman et. al. Linkage of early-onset familial breast cancer to chromosome 17q21 Science 250 1990 1684-1689
3. D.F. Easton D.T. Bishop D. Ford G.P. Crockford Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. The Breast Cancer Linkage Consortium Am J Hum Genet 52 1993 678-701
4. Y. Miki J. Swensen D. Shattuck-Eidens et. al. A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1 Science 266 1994 66-71
5. R. Wooster S.L. Neuhausen J. Mangion et. al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 Science 265 1994 2088-2090
6. C.E. Land M. Tokunaga K. Koyana et. al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990 Radiat Res 160 2003 707-717
7. A.G. Knudson H.W. Hethcote B.W. Brown Mutation and childhood cancer: A probabilistic model for the incidence of retinoblastoma Proc Natl Acad Sci U S A 72 1975 5116-5120
8. S.N. Powell L.A. Kachnic Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation Oncogene 22 2003 5784-5791
9. D. Cortez Y. Wang J. Qin S.J. Elledge Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks Science 286 1999 1162-1166
10. R.I. Yarden S. Pardo-Reoyo M. Sgagias K.H. Cowan L.C. Brody BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage Nat Genet 30 2002 285-289
11. J.J. Chen D. Silver S. Cantor D.M. Livingston R. Scully BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway Cancer Res 59 1999 1752s-1756s
12. N.G. Howlett T. Taniguchi S. Olson et. al. Biallelic inactivation of BRCA2 in Fanconi anemia Science 297 2002 606-609
13. P.A. Futreal Q. Liu D. Shattuck-Eidens et. al. BRCA1 mutations in primary breast and ovarian carcinomas Science 266 1994 120-122
14. J.M. Lancaster R. Wooster J. Mangion et. al. BRCA2 mutations in primary breast and ovarian cancers Nat Genet 13 1996 238-240
15. D.F. Easton D. Ford D.T. Bishop Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium Am J Hum Genet 56 1995 265-271
16. D. Thompson D.F. Easton The BRCA1 and BRCA2 genes R.A. Eeles D.F. Easton B.A.J. Ponder C. Eng Genetic predisposition to cancer 2004 Arnold London
17. S.A. Smith D.F. Easton D.G. Evans B.A. Ponder Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome Nat Genet 2 1992 128-131
18. N. Collins R. McManus R. Wooster et. al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13 Oncogene 10 1995 1673-1675
19. J. Peto N. Collins R. Barfoot et. al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 91 1999 943-949
20. D.P. Lane Cancer. p53, Guardian of the genome Nature 358 1992 15-16
21. F.P. Li J.F. Fraumeni Jr. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome J Natl Cancer Inst 43 1969 1365-1373
22. J.M. Varley M. Thorncroft G. McGown et. al. A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene Oncogene 14 1997 865-871
23. D. Dittmer S. Pati G. Zambetti et. al. Gain of function mutations in p53 Nat Genet 4 1993 42-46
24. C. Le Bihan C. Bonaiti-Pellie A method for estimating cancer risk in p53 mutation carriers Cancer Detect Prev 18 1994 171-178
25. K.E. Nichols D. Malkin J.E. Garber J.F. Fraumeni Jr. F.P. Li Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers Cancer Epidemiol Biomarkers Prev 10 2001 83-87
26. J.M. Birch R.D. Alston R.J. McNally et. al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations Oncogene 20 2001 4621-4628
27. Eeles RA. Germline and somatic mutations in the TP53 gene in breast and other Cancers. PhD Thesis, University of London, London, 2000.
28. M.R. Nelen G.W. Padberg E.A. Peeters et. al. Localization of the gene for Cowden disease to chromosome 10q22-23 Nat Genet 13 1996 114-116
29. M. Tamura J. Gu K. Matsumoto S. Aota R. Parsons K.M. Yamada Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Science 280 1998 1614-1617
30. D. Kong A. Suzuki T.T. Zou et. al. PTEN1 is frequently mutated in primary endometrial carcinomas Nat Genet 17 1997 143-144
31. M.R. Nelen W.C. van Staveren E.A. Peeters et. al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease Hum Mol Genet 6 1997 1383-1387
32. G.W. Padberg J.D. Schot G.J. Vielvoye G.T. Bots F.C. de Beer Lhermitte-Duclos disease and Cowden disease: A single phakomatosis Ann Neurol 29 1991 517-523
33. C. Eng Cowden syndrome R.A. Eeles D.F. Easton B.A.J. Ponder et. al. Genetic predisposition to cancer 2004 Arnold London
34. M. Swift D. Morrell R.B. Massey C.L. Chase Incidence of cancer in 161 families affected by ataxia-telangiectasia N Engl J Med 325 1991 1831-1836
35. D.F. Easton Cancer risks in A-T heterozygotes Int J Radiat Biol 66 1994 S177-S182
36. G. Chenevix-Trench A.B. Spurdle M. Gatei et. al. Dominant negative ATM mutations in breast cancer families J Natl Cancer Inst 94 2002 205-215
37. D. Thompson A.C. Antoniou M. Jenkins et. al. Two ATM variants and breast cancer risk Hum Mutat 25 2005 594-595
38. H. Kaneko T. Fukao N. Kondo The function of RecQ helicase gene family (especially BLM) in DNA recombination and joining Adv Biophys 38 2004 45-64
39. J. German Bloom's syndrome. XX. The first 100 cancers Cancer Genet Cytogenet 93 1997 100-106
40. A.D. Spigelman V. Murday R.K. Phillips Cancer and the Peutz-Jeghers syndrome Gut 30 1989 1588-1590
41. F.M. Giardiello S.B. Welsh S.R. Hamilton et. al. Increased risk of cancer in the Peutz-Jeghers syndrome N Engl J Med 316 1987 1511-1514
42. F.M. Giardiello J.D. Brensinger A.C. Tersmette et. al. Very high risk of cancer in familial Peutz-Jeghers syndrome Gastroenterology 119 2000 1447-1453
43. H. Itoh R.S. Houlston C. Harocopos J. Slack Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): A study of 130 kindreds in the United Kingdom Br J Surg 77 1990 1367-1370
44. J. Falck N. Mailand R.G. Syljuasen J. Bartek J. Lukas The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis Nature 410 2001 842-847
45. H. Meijers-Heijboer O.A. van den J. Klijn et. al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 2002 55-59
46. T.G. Krontiris B. Devlin D.D. Karp N.J. Robert N. Risch An association between the risk of cancer and mutations in the HRAS1 minisatellite locus N Engl J Med 329 1993 517-523
47. S.A. Fuqua G.C. Chamness W.L. McGuire Estrogen receptor mutations in breast cancer J Cell Biochem 51 1993 135-139
48. L.M. Bennett Breast cancer: Genetic predisposition and exposure to radiation Mol Carcinog 26 1999 143-149
49. L.B. Travis D. Hill G.M. Dores et. al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma J Natl Cancer Inst 97 2005 1428-1437
50. G.R. Howe J. McLaughlin Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study Radiat Res 145 1996 694-707
51. D. Scott J.B. Barber E.L. Levine W. Burrill S.A. Roberts Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: A test for predisposition? Br J Cancer 77 1998 614-620
52. W. Burrill J.B. Barber S.A. Roberts B. Bulman D. Scott Heritability of chromosomal radiosensitivity in breast cancer patients: A pilot study with the lymphocyte micronucleus assay Int J Radiat Biol 76 2000 1617-1619
53. T.M. Pawlik K. Keyomarsi Role of cell cycle in mediating sensitivity to radiotherapy Int J Radiat Oncol Biol Phys 59 2004 928-942
54. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2002 171-182
55. D.W. Abbott M.L. Freeman J.T. Holt Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells J Natl Cancer Inst 90 1998 978-985
56. M. Morimatsu G. Donoho P. Hasty Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence Cancer Res 58 1998 3441-3447
57. R. Scully S. Ganesan K. Vlasakova J. Chen M. Socolovsky D.M. Livingston Genetic analysis of BRCA1 function in a defined tumor cell line Mol Cells 4 1999 1093-1099
58. H. Wang Z.C. Zeng T.A. Bui et. al. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2 Cancer Res 61 2001 270-277
59. B. Nieuwenhuis A.J. Assen-Bolt M.A. Waarde-Verhagen et. al. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage Int J Radiat Biol 78 2002 285-295
60. A. Baeyens H. Thierens K. Claes B. Poppe L. de Ridder A. Vral chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers Int J Radiat Biol 80 2004 745-756
61. K. Trenz A. Rothfuss P. Schutz G. Speit Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation Mutat Res 500 2002 89-96
62. K. Trenz J. Landgraf G. Speit Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation Breast Cancer Res Treat 78 2003 69-79
63. V.L. Cressman D.C. Backlund E.M. Hicks L.C. Gowen V. Godfrey B.H. Koller Mammary tumor formation in p53- and brca1-deficient mice Cell Growth Differ 10 1999 1-10
64. S.K. Sharan M. Morimatsu U. Albrecht et. al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 Nature 386 1997 804-810
65. J.D. Boice Jr. E.B. Harvey M. Blettner M. Stovall J.T. Flannery Cancer in the contralateral breast after radiotherapy for breast cancer N Engl J Med 326 1992 781-785
66. D. Eccles P. Simmonds J. Goddard et. al. Familial breast cancer: An investigation into the outcome of treatment for early stage disease Fam Cancer 1 2001 65-72
67. E. Chabner A. Nixon R. Gelman et. al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer J Clin Oncol 16 1998 2045-2051
68. D.K. Gaffney R.M. Brohet C.M. Lewis et. al. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations Radiother Oncol 47 1998 129-136
69. L.J. Pierce M. Strawderman S.A. Narod et. al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations J Clin Oncol 18 2000 3360-3369
70. M. Robson D. Levin M. Federici et. al. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations J Natl Cancer Inst 91 1999 2112-2117
71. M. Robson T. Svahn B. McCormick et. al. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic-based series Cancer 103 2005 44-51
72. B.G. Haffty E. Harrold A.J. Khan et. al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 2002 1471-1477
73. D. Ford D.F. Easton D.T. Bishop S.A. Narod D.E. Goldgar Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium Lancet 343 1994 692-695
74. Y.M. Kirova D. Stoppa-Lyonnet A. Savignoni et. al. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy Eur J Cancer 41 2005 2304-2311
75. B.C. Turner E. Harrold E. Matloff et. al. BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: Implications for breast-conserving management in patients with BRCA1/BRCA2 mutations J Clin Oncol 17 1999 3017-3024
76. T. Leong J. Whitty M. Keilar et. al. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients Int J Radiat Oncol Biol Phys 48 2000 959-965
77. R. Chakraborty K. Sankaranarayanan Mutations in the BRCA1 gene: implications of inter-population differences for predicting the risk of radiation-induced breast cancers Genet Res 72 1998 191-198
78. M.O. Leach C.R. Boggis A.K. Dixon et. al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS) Lancet 365 2005 1769-1778
79. P. Fei W.S. El Deiry P53 and radiation responses Oncogene 22 2003 5774-5783
80. F.P. Li J.F. Fraumeni Jr. Prospective study of a family cancer syndrome JAMA 247 1982 2692-2694
81. C. Barlow M.A. Eckhaus A.A. Schaffer A. Wynshaw-Boris Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice Nat Genet 21 1999 359-360
82. A.M.R. Taylor G. Stewart T. Stankovic S. Man P.J. Byrd Clinical, cellular and mutational variations in ataxia telangiectasia R.A. Eeles D.F. Easton B.A.J. Ponder C. Eng Genetic predisposition to cancer 2004 Arnold London Chapter 13
83. A. Broeks L. de Witte A. Nooijen et. al. Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers Breast Cancer Res Treat 83 2004 91-93
84. M. Higurashi P.E. Conen In vitro chromosomal radiosensitivity in 'chromosomal breakage syndromes' Cancer 32 1973 380-383
85. A. Tachibana Genetic and physiological regulation of non-homologous end-joining in mammalian cells Adv Biophys 38 2004 21-44
86. M.D. Tischkowitz S.V. Hodgson Fanconi anaemia J Med Genet 40 2003 1-10
87. E. Gluckman A. Devergie J. Dutreix Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation Br J Haematol 54 1983 431-440
88. Y. Marcou A. D'Andrea P.A. Jeggo P.N. Plowman Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity Radiother Oncol 60 2001 75-79
89. D.S. Lim S.T. Kim B. Xu et. al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway Nature 404 2000 613-617
90. M. Digweed A. Reis K. Sperling Nijmegen breakage syndrome: Consequences of defective DNA double strand break repair Bioessays 21 1999 649-656
91. P.T. Ozand M. Waghray J.D. Cook K. Sheth G.G. Gascon Riyadh chromosome breakage syndrome: Mental retardation with depigmentation of the skin and hair J Child Neurol 7 Suppl 1992 S79-S82
92. M.F. Borg I.N. Olver M.P. Hill Rothmund-Thomson syndrome and tolerance of chemoradiotherapy Australas Radiol 42 1998 216-218
93. L.L. Wang M.L. Levy R.A. Lewis et. al. Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients Am J Med Genet 102 2001 11-17
94. T. Featherstone A.M. Taylor D.G. Harnden Studies on the radiosensitivity of cells from patients with basal cell naevus syndrome Am J Hum Genet 35 1983 58-66
95. S. Palanduz A. Palanduz I. Yalcin et. al. In vitro chromosomal radiosensitivity in common variable immune deficiency Clin Immunol Immunopathol 86 1998 180-182
96. I. Vorechovsky D. Scott M.R. Haeney D.A. Webster Chromosomal radiosensitivity in common variable immune deficiency Mutat Res 290 1993 255-264
97. K.K. Sanford R. Parshad F.M. Price R.E. Tarone W.F. Benedict Cytogenetic responses to G2 phase X-irradiation of cells from retinoblastoma patients Cancer Genet Cytogenet 88 1996 43-48
98. J.E. Morten D.G. Harnden A.M. Taylor Chromosome damage in G0 X-irradiated lymphocytes from patients with hereditary retinoblastoma Cancer Res 41 1981 3635-3638
99. L.L. Chan B.A. Czerniak L.E. Ginsberg Radiation-induced osteosarcoma after bilateral childhood retinoblastoma AJR Am J Roentgenol 174 2000 1288
100. T. Murray Cancer incidence after retinoblastoma: Radiation dose and sarcoma risk Surv Ophthalmol 43 1998 288-289
101. A.C. Moll S.M. Imhof A.Y. Schouten-Van Meeteren D.J. Kuik P. Hofman M. Boers Second primary tumors in hereditary retinoblastoma: A register-based study, 1945-1997: Is there an age effect on radiation-related risk? Ophthalmology 108 2001 1109-1114
102. H.M. Shafik W.W. Au M.S. Legator Chromosomal radiosensitivity of Down syndrome lymphocytes at different stages of the cell cycle Hum Genet 78 1988 71-75
103. M.S. Sasaki A. Tonomura S. Matsubara Chromosome constitution and its bearing on the chromosomal radiosensitivity in man Mutat Res 10 1970 617-633
104. O. Imamura K. Fujita C. Itoh et. al. Werner and Bloom helicases are involved in DNA repair in a complementary fashion Oncogene 21 2002 954-963